RESUMEN
The purpose of this study was to determine the sensitivity and specificity of optical coherence tomography (OCT) under two well-defined clinical settings. First, as an aid to cervical cancer screening, using visual inspection with acetic acid (VIA) in low-resource settings, and the second, as an adjunct to the traditional management of abnormal cervical cytology with colposcopy and biopsy. Patients referred for colposcopy with > or = atypical squamous cells of undetermined significance were accrued for the study. Each subject underwent VIA and colposcopy. OCT was performed in all VIA- and colposcopy-positive areas and at the squamocolumnar junction in all four quadrants. The sensitivity of VIA for > or = cervical intraepithelial neoplasia 2 was 76% (95% CI 58-88). When OCT was applied to VIA as a secondary screen, the specificity improved from 34% (95% CI 27-41) to 61% (95% CI 60-74). With liberal diagnostic criteria for the majority of the colposcopy examinations, OCT showed an even greater relative improvement in specificity. OCT proved to be a fair diagnostic modality (receiver operating characteristic curve 0.73) adjunctive to VIA and colposcopy. On the basis of the above findings, we believe that this technology could potentially show greatest utility in the management of cervical dysplasia in low-resource settings where a single episode of care is most desirable.
Asunto(s)
Colposcopía/métodos , Tomografía de Coherencia Óptica , Displasia del Cuello del Útero/diagnóstico , Neoplasias del Cuello Uterino/diagnóstico , Adolescente , Adulto , Anciano , Cuello del Útero/patología , Femenino , Humanos , Persona de Mediana Edad , Sensibilidad y EspecificidadRESUMEN
The authors describe a 49-year-old woman (R.K.) who presented with one year of progressive frontal lobe dysfunction, including signs of expressive aphasia. Signs of parkinsonism were absent until late in the clinical course. Neuropsychologic testing and neuroimaging studies are described. The patient died at age 55, after 7 years of symptoms. Family history was remarkable for a mother who died at the age of 45, after experiencing 7 years of progressive aphasia. R.K.'s brain showed asymmetric frontotemporal atrophy, which was more severe on the left side. Histopathologic analysis was remarkable for numerous tau-positive neurons with some classic-appearing Pick bodies and many ballooned neurons. Tau-positive glial cells were also present. The authors suggest that the abnormal tau aggregates are related to the symptoms experienced by affected members of this family.
Asunto(s)
Encéfalo/patología , Demencia/patología , Neuroglía/patología , Neuronas/patología , Proteínas tau/metabolismo , Afasia/genética , Demencia/genética , Femenino , Lateralidad Funcional , Humanos , Persona de Mediana Edad , Pruebas Neuropsicológicas , LinajeRESUMEN
Ablation of nonmuscle myosin heavy chain II-B (NMHC-B) in mice results in severe hydrocephalus with enlargement of the lateral and third ventricles. All B(-)/B(-) mice died either during embryonic development or on the day of birth (PO). Neurons cultured from superior cervical ganglia of B(-)/B(-) mice between embryonic day (E) 18 and P0 showed decreased rates of neurite outgrowth, and their growth cones had a distinctive narrow morphology compared with those from normal mice. Serial sections of E12.5, E13.5, and E15 mouse brains identified developmental defects in the ventricular neuroepithelium. On E12.5, disruption of the coherent ventricular surface and disordered cell migration of neuroepithelial and differentiated cells were seen at various points in the ventricular walls. These abnormalities resulted in the formation of rosettes in various regions of the brain and spinal cord. On E13.5 and E15, disruption of the ventricular surface and aberrant protrusions of neural cells into the ventricles became more prominent. By E18.5 and P0, the defects in cells lining the ventricular wall resulted in an obstructive hydrocephalus due to stenosis or occlusion of the third ventricle and cerebral aqueduct. These defects may be caused by abnormalities in the cell adhesive properties of neuroepithelial cells and suggest that NMHC-B is essential for both early and late developmental processes in the mammalian brain.
Asunto(s)
Ventrículos Cerebrales/anomalías , Cadenas Pesadas de Miosina/genética , Miosinas/genética , Animales , Adhesión Celular , Movimiento Celular , Células Cultivadas , Citoesqueleto/patología , Femenino , Feto/anomalías , Hidrocefalia/patología , Hidrocefalia/fisiopatología , Ratones , Ratones Noqueados , Neuronas/citología , EmbarazoRESUMEN
CD26 or dipeptidyl peptidase IV (DP IV) is expressed on various cell types, including T cells. Although T cells can receive activating signals via CD26, the physiological role of CD26/DP IV is largely unknown. We used the reversible DP IV inhibitor Lys[Z(NO(2))]-pyrrolidide (I40) to dissect the role of DP IV in experimental autoimmune encephalomyelitis (EAE) and to explore the therapeutic potential of DP IV inhibition for autoimmunity. I40 administration in vivo decreased and delayed clinical and neuropathological signs of adoptive transfer EAE. I40 blocked DP IV activity in vivo and increased the secretion of the immunosuppressive cytokine TGF-beta1 in spinal cord tissue and plasma during acute EAE. In vitro, while suppressing autoreactive T cell proliferation and TNF-alpha production, I40 consistently up-regulated TGF-beta1 secretion. A neutralizing anti-TGF-beta1 Ab blocked the inhibitory effect of I40 on T cell proliferation to myelin Ag. DP IV inhibition in vivo was not generally immunosuppressive, neither eliminating encephalitogenic T cells nor inhibiting T cell priming. These data suggest that DP IV inhibition represents a novel and specific therapeutic approach protecting from autoimmune disease by a mechanism that includes an active TGF-beta1-mediated antiinflammatory effect at the site of pathology.
Asunto(s)
Dipeptidil Peptidasa 4/metabolismo , Encefalomielitis Autoinmune Experimental/enzimología , Encefalomielitis Autoinmune Experimental/prevención & control , Factor de Crecimiento Transformador beta/metabolismo , Regulación hacia Arriba , Animales , División Celular/inmunología , Células Cultivadas , Encefalomielitis Autoinmune Experimental/inmunología , Encefalomielitis Autoinmune Experimental/patología , Activación Enzimática/efectos de los fármacos , Activación Enzimática/inmunología , Femenino , Adyuvante de Freund/administración & dosificación , Inhibidores de Crecimiento/fisiología , Terapia de Inmunosupresión , Inyecciones Intraperitoneales , Inyecciones Subcutáneas , Activación de Linfocitos , Lisina/administración & dosificación , Lisina/análogos & derivados , Lisina/farmacología , Ratones , Proteína Básica de Mielina/administración & dosificación , Proteína Básica de Mielina/inmunología , Inhibidores de Proteasas/administración & dosificación , Inhibidores de Proteasas/farmacología , Pirrolidinas/administración & dosificación , Pirrolidinas/farmacología , Subgrupos de Linfocitos T/inmunología , Factor de Crecimiento Transformador beta/biosíntesis , Factor de Crecimiento Transformador beta/fisiología , Factor de Crecimiento Transformador beta1 , Regulación hacia Arriba/efectos de los fármacos , Regulación hacia Arriba/inmunologíaRESUMEN
Mature T cells initially respond to Ag by activation and expansion, but high and repeated doses of Ag cause programmed cell death and can suppress T cell-mediated diseases in rodents. We evaluated repeated systemic Ag administration in a marmoset model of experimental allergic encephalomyelitis that closely resembles the human disease multiple sclerosis. We found that treatment with MP4, a chimeric, recombinant polypeptide containing human myelin basic protein and human proteolipid protein epitopes, prevented clinical symptoms and did not exacerbate disease. CNS lesions were also reduced as assessed in vivo by magnetic resonance imaging. Thus, specific Ag-directed therapy can be effective and nontoxic in primates.
Asunto(s)
Callithrix/inmunología , Epítopos Inmunodominantes/inmunología , Inmunoterapia Activa/métodos , Esclerosis Múltiple/inmunología , Esclerosis Múltiple/terapia , Proteína Básica de Mielina/inmunología , Proteína Proteolipídica de la Mielina/inmunología , Animales , Autoanticuerpos/biosíntesis , Encéfalo/patología , Citocinas/biosíntesis , Modelos Animales de Enfermedad , Relación Dosis-Respuesta Inmunológica , Esquema de Medicación , Epítopos Inmunodominantes/administración & dosificación , Inmunosupresores/administración & dosificación , Inmunosupresores/inmunología , Inyecciones Intravenosas , Activación de Linfocitos/inmunología , Imagen por Resonancia Magnética , Masculino , Esclerosis Múltiple/patología , Proteína Básica de Mielina/administración & dosificación , Proteína Proteolipídica de la Mielina/administración & dosificación , Proteínas Recombinantes de Fusión/administración & dosificación , Proteínas Recombinantes de Fusión/inmunología , Células TH1/inmunología , Células TH1/metabolismo , Células Th2/inmunología , Células Th2/metabolismoRESUMEN
In mammalian cells, regulation of the expression of proteins involved in iron metabolism is achieved through interactions of iron-sensing proteins known as iron regulatory proteins (IRPs), with transcripts that contain RNA stem-loop structures referred to as iron responsive elements (IREs). Two distinct but highly homologous proteins, IRP1 and IRP2, bind IREs with high affinity when cells are depleted of iron, inhibiting translation of some transcripts, such as ferritin, or turnover of others, such as the transferrin receptor (TFRC). IRPs sense cytosolic iron levels and modify expression of proteins involved in iron uptake, export and sequestration according to the needs of individual cells. Here we generate mice with a targeted disruption of the gene encoding Irp2 (Ireb2). These mutant mice misregulate iron metabolism in the intestinal mucosa and the central nervous system. In adulthood, Ireb2(-/-) mice develop a movement disorder characterized by ataxia, bradykinesia and tremor. Significant accumulations of iron in white matter tracts and nuclei throughout the brain precede the onset of neurodegeneration and movement disorder symptoms by many months. Ferric iron accumulates in the cytosol of neurons and oligodendrocytes in distinctive regions of the brain. Abnormal accumulations of ferritin colocalize with iron accumulations in populations of neurons that degenerate, and iron-laden oligodendrocytes accumulate ubiquitin-positive inclusions. Thus, misregulation of iron metabolism leads to neurodegenerative disease in Ireb2(-/-) mice and may contribute to the pathogenesis of comparable human neurodegenerative diseases.
Asunto(s)
Proteínas Hierro-Azufre/genética , Hierro/metabolismo , Trastornos del Movimiento/genética , Enfermedades Neurodegenerativas/genética , Proteínas de Unión al ARN/genética , Animales , Cerebelo/patología , Duodeno/patología , Ferritinas/metabolismo , Eliminación de Gen , Mucosa Intestinal/patología , Proteína 1 Reguladora de Hierro , Proteína 2 Reguladora de Hierro , Proteínas Reguladoras del Hierro , Ratones , Ratones Mutantes , Datos de Secuencia Molecular , Neuronas/patología , Oligodendroglía/patología , Células de Purkinje/patología , Putamen/patología , Elementos de Respuesta , Tálamo/patología , Ubiquitinas/metabolismoRESUMEN
Current pathogenic concepts of inflammatory demyelinating disorders such as multiple sclerosis (MS) are based on the hypothesis that a T cell-mediated autoimmune response is involved in the disease process. One of the primary goals in the in the development of immunotherapies for autoimmune diseases has been to achieve inactivation of disease-inducing lymphocytes either by direct inhibition or suppression through regulatory cells and/or cytokines. The CD26 antigen is identical with the cell surface ectopeptidase dipeptidyl peptidase IV (DP IV, EC 3.4.14.5) which is involved in regulating T cell activation and growth. Activated T cells, including those specific for myelin antigens, express high levels of CD26/DP IV. In vitro, reversible DP IV inhibitors suppress T cell proliferation and pro-inflammatory cytokine production in response to myelin antigens. Further studies will evaluate the role of DP IV inhibition in T cell-mediated inflammatory disease of the central nervous system.
Asunto(s)
Enfermedades Autoinmunes/enzimología , Dipeptidil Peptidasa 4/fisiología , Encefalomielitis Autoinmune Experimental/enzimología , Activación de Linfocitos , Lisina/análogos & derivados , Esclerosis Múltiple/enzimología , Proteína Básica de Mielina/inmunología , Pirrolidinas/farmacología , Inhibidores de Serina Proteinasa/farmacología , Subgrupos de Linfocitos T/efectos de los fármacos , Tiazoles/farmacología , Animales , Animales no Consanguíneos , Enfermedades Autoinmunes/tratamiento farmacológico , Dipeptidil Peptidasa 4/efectos de los fármacos , Encefalomielitis Autoinmune Experimental/tratamiento farmacológico , Femenino , Humanos , Activación de Linfocitos/efectos de los fármacos , Lisina/farmacología , Ratones , Ratas , Inhibidores de Serina Proteinasa/uso terapéutico , Subgrupos de Linfocitos T/enzimología , Subgrupos de Linfocitos T/inmunología , Linfocitos T Colaboradores-Inductores/enzimología , Linfocitos T Colaboradores-Inductores/inmunologíaRESUMEN
In human immunodeficiency virus (HIV)-infected individuals, the level of the HIV envelope protein gp41 in brain tissue is correlated with neurological damage and dementia. In this paper we show by biochemical methods and electron microscopy that the extracellular ectodomain of purified HIV and simian immunodeficiency virus gp41 (e-gp41) forms a mixture of soluble high molecular weight aggregate and native trimer at physiological pH. The e-gp41 aggregate is shown to be largely alpha-helical and relatively stable to denaturants. The high molecular weight form of e-gp41 is variable in size ranging from 7 to 70 trimers, which associate by interactions at the interior of the aggregate involving the loop that connects the N- and C-terminal helices of the e-gp41 core. The trimers are predominantly arranged with their long axes oriented radially, and the width of the high molecular weight aggregate corresponds to the length of two e-gp41 trimers (approximately 200 A). Using both light and electron microscopy combined with immunohistochemistry we show that HIV gp41 accumulates as an extracellular aggregate in the brains of HIV-infected patients diagnosed with dementia. We postulate that the high molecular weight aggregates of e-gp41 are responsible for HIV-associated neurological damage and dementia, consistent with known mechanisms of encephalopathy.
Asunto(s)
Complejo SIDA Demencia/genética , Encefalopatías/virología , Proteína gp41 de Envoltorio del VIH/química , Proteína gp41 de Envoltorio del VIH/metabolismo , Complejo SIDA Demencia/patología , Encéfalo/patología , Encéfalo/ultraestructura , Encéfalo/virología , Encefalopatías/genética , Cromatografía en Gel , Endopeptidasas/metabolismo , Espacio Extracelular/metabolismo , Proteína gp41 de Envoltorio del VIH/ultraestructura , Seropositividad para VIH/complicaciones , Humanos , Concentración de Iones de Hidrógeno , Inmunohistoquímica , Glicoproteínas de Membrana/química , Glicoproteínas de Membrana/metabolismo , Glicoproteínas de Membrana/ultraestructura , Microscopía Electrónica , Unión Proteica , Estructura Terciaria de Proteína , Proteínas de los Retroviridae/química , Proteínas de los Retroviridae/metabolismo , Proteínas de los Retroviridae/ultraestructuraRESUMEN
Experimental allergic encephalomyelitis (EAE) was induced in the NIH minipig to create a large animal model of multiple sclerosis with a well-characterized immune system. Sixteen NIH minipigs were inoculated with minipig spinal cord homogenate (SCH). The clinical course was primarily monophasic, but re-induction was possible. CNS and blood lymphocytes specifically proliferated to SCH. Flow cytometry of CNS-isolated cells and SCH-stimulated PBMC revealed a shift to CD4(+) CD8(+) cells. Pathology demonstrated demyelination in the CNS white matter with perivascular mononuclear cell infiltrates of CD3(+)CD4(+)CD45(+) lymphocytes with a subset CD8(+). Pathology and in vitro SCH responses implicate a central role of CD4(+) lymphocytes in swine EAE.
Asunto(s)
Encefalomielitis Autoinmune Experimental/etiología , Animales , Encéfalo/inmunología , Modelos Animales de Enfermedad , Encefalomielitis Autoinmune Experimental/inmunología , Encefalomielitis Autoinmune Experimental/patología , Femenino , Citometría de Flujo , Inmunohistoquímica , Activación de Linfocitos , Esclerosis Múltiple/etiología , Porcinos , Porcinos EnanosRESUMEN
Complete ablation of nonmuscle myosin heavy chain II-B (NMHC-B) in mice resulted in cardiac and brain defects that were lethal during embryonic development or on the day of birth. In this paper, we report on the generation of mice with decreased amounts of NMHC-B. First, we generated B(DeltaI)/B(DeltaI) mice by replacing a neural-specific alternative exon with the PGK-Neo cassette. This resulted in decreased amounts of NMHC-B in all tissues, including a decrease of 88% in the heart and 65% in the brain compared with B(+)/B(+) tissues. B(DeltaI)/B(DeltaI) mice developed cardiac myocyte hypertrophy between 7 months and 11 months of age, at which time they reexpressed the cardiac beta-MHC. Serial sections of B(DeltaI)/B(DeltaI) brains showed abnormalities in neural cell migration and adhesion in the ventricular wall. Crossing B(DeltaI)/B(DeltaI) with B(+)/B(-) mice generated B(DeltaI)/B(-) mice, which showed a further decrease of approximately 55% in NMHC-B in the heart and brain compared with B(DeltaI)/B(DeltaI) mice. Five of 8 B(DeltaI)/B(-) mice were born with a membranous ventricular septal defect. Moreover, 5 of 5 B(DeltaI)/B(-) mice developed myocyte hypertrophy by 1 month; B(DeltaI)/B(-) mice also reexpressed the cardiac beta-MHC. More than 60% of B(DeltaI)/B(-) mice developed overt hydrocephalus and showed more severe defects in neural cell migration and adhesion than did B(DeltaI)/B(DeltaI) mice. These data on B(DeltaI)/B(DeltaI) and B(DeltaI)/B(-) mice demonstrate a gene dosage effect of the amount of NMHC-B on the severity and time of onset of the defects in the heart and brain.
Asunto(s)
Encéfalo/patología , Dosificación de Gen , Miocardio/patología , Cadenas Pesadas de Miosina/genética , Animales , Tamaño de la Célula , Defectos de los Tabiques Cardíacos/genética , Histocitoquímica , Hidrocefalia/genética , Kanamicina Quinasa/genética , Imagen por Resonancia Magnética , Ratones , Cadenas Pesadas de Miosina/deficiencia , Fenotipo , Fosfoglicerato Quinasa/genéticaRESUMEN
In multiple sclerosis (MS) patients, a coordinated attack of the immune system against the primary constituents of oligodendrocytes and/or the myelin sheath of oligodendrocytes results in the formation of lesions in the brain and spinal cord. Thus far, however, a limited number of genes that potentially contribute to lesion pathology have been identified. Using cDNA microarray technology, we have performed experiments on MS tissue monitoring the expression pattern of over 5,000 genes and compared the gene expression profile of normal white matter with that found in acute lesions from the brain of a single MS patient. Sixty-two differentially expressed genes were identified, including the Duffy chemokine receptor, interferon regulatory factor-2, and tumor necrosis factor alpha receptor-2 among others. Thus, cDNA microarray technology represents a powerful new tool for the identification of genes not previously associated with the MS disease process.
Asunto(s)
ADN Complementario , Expresión Génica/genética , Esclerosis Múltiple/genética , Esclerosis Múltiple/patología , Hibridación de Ácido Nucleico/métodos , Análisis de Secuencia por Matrices de Oligonucleótidos/métodos , Encéfalo/patología , Humanos , InmunohistoquímicaRESUMEN
BACKGROUND AND PURPOSE: Experimental autoimmune encephalomyelitis (EAE) in the marmoset was monitored by serial MR imaging to determine correlates to the natural-history MR studies in multiple sclerosis (MS). The relationships of MR-revealed lesions to clinical status and histopathologic findings were also explored. METHODS: We induced EAE by subcutaneous inoculation in two marmosets by human white matter (HWM) and in seven marmosets by MP4 (a chimeric recombinant fusion protein of myelin-basic and proteolipid protein) in adjuvant along with intravenous inactivated pertussis vaccine to facilitate the disease process. The HWM-inoculated animals were induced with Freund's adjuvant as the established model of marmoset EAE. The MP4-inoculated animals were induced with either Freund's incomplete adjuvant or TiterMax as part of a preclinical treatment trial. MR imaging was performed at 1.5 T at baseline, and repeated at 1- to 2-week intervals for a period of up to 16 weeks in six EAE-induced marmosets, and intermittently for up to 70 weeks in three EAE-induced and two control marmosets. Proton density- (PD-) and T2-weighted, pre- and postgadopentetate dimeglumine enhancement, T1-weighted, and magnetization transfer (MT) images were obtained. The brains were prepared for histologic evaluation of lesion distribution and counts, characterization of lesions as demyelinating or inflammatory, and histopathologic scoring. The clinical, MR, and pathologic scoring were done on grading systems, and correlated for evaluation. RESULTS: White matter (WM) changes after EAE induction were observed first at 9 days in the HWM-induced animals and at 2.5 weeks in the MP4-induced animals, with subsequent week-to-week fluctuations on PD- and T2-weighted images. Contrast-enhancing lesions were not observed in all animals. MR-revealed WM lesions correlated to histopathologic analysis of EAE lesions, measuring from 0.5 mm to 1.5 mm. The lesion count and extent of demyelination was greater in the HWM-induced animals than in the MP4-induced animals. Some MR-revealed lesions correlated directly to clinical symptoms, but the majority of lesions were clinically silent. CONCLUSION: On MR images, lesions in the EAE marmoset model were confined to the WM, and their development, resolution, distribution, and enhancing characteristics fluctuated over the duration of the study. The dynamic presentation of MR-revealed lesions confirms the parallels between EAE in the marmoset and relapsing-remitting MS. Clinical symptoms alone were not representative of ongoing pathologic brain lesions. Therefore, serial MR imaging serves as a very important adjunct to clinical and histologic surveillance of the development of new and the persistence of existing brain lesions in this animal model of MS.
Asunto(s)
Encefalomielitis Autoinmune Experimental/diagnóstico , Imagen por Resonancia Magnética , Animales , Encéfalo/patología , Trasplante de Tejido Encefálico/inmunología , Callithrix , Niño , Preescolar , Quimera/inmunología , Encefalomielitis Autoinmune Experimental/inmunología , Encefalomielitis Autoinmune Experimental/patología , Femenino , Humanos , Lactante , Masculino , Proteína Básica de Mielina/genética , Proteína Proteolipídica de la Mielina/genética , Proteínas Recombinantes de Fusión/inmunología , Médula Espinal/patologíaRESUMEN
In an attempt to understand the mechanisms of cell injury in the inflammatory myopathies, we analyzed the expression of costimulatory molecules, CTLA4, CD28, CD86, CD40, and CD154 as well as HLA class I, HLA class II, and ICAM-I in normal muscle and in muscle biopsies from patients with polymyositis (PM) or dermatomyositis (DM). By immunohistochemical staining, DM and PM biopsies showed the presence of CTLA4, CD28, CD86, and CD40 on inflammatory cells. More strikingly, however, low levels of CTLA4 and CD28 were observed on muscle cells. The expression of CTLA4 and CD28 on nonlymphoid cells has not been previously reported. These unexpected findings were confirmed in cultured normal human myoblasts: various proinflammatory cytokines induced the expression of CTLA4 and CD28 on normal human muscle cells. The sequences of the cDNAs were found to be identical to the sequences for these molecules in T cells. The data suggest a novel complexity in the network of cellular interactions between the infiltrated immune cells and the muscle cells in which the normal relationship between infiltrating inflammatory cells and target tissue is under a previously unrecognized set of controls.
Asunto(s)
Antígenos CD/biosíntesis , Antígenos de Diferenciación/biosíntesis , Dermatomiositis/inmunología , Antígenos de Histocompatibilidad Clase II/biosíntesis , Antígenos de Histocompatibilidad Clase I/biosíntesis , Inmunoconjugados , Molécula 1 de Adhesión Intercelular/biosíntesis , Músculo Esquelético/inmunología , Polimiositis/inmunología , Abatacept , Adulto , Antígenos CD/genética , Antígenos de Diferenciación/genética , Antígeno B7-2 , Biomarcadores , Antígenos CD28/biosíntesis , Antígenos CD28/genética , Antígenos CD40/biosíntesis , Ligando de CD40 , Antígeno CTLA-4 , Células Cultivadas , Dermatomiositis/patología , Femenino , Expresión Génica , Humanos , Glicoproteínas de Membrana/biosíntesis , Persona de Mediana Edad , Músculo Esquelético/citología , Polimiositis/patologíaRESUMEN
Negative sellar exploration (despite the results of endocrine evaluation indicating Cushing's disease), the high incidence of failure of total hypophysectomy, and remission of Cushing's syndrome after unsuccessful hypophysectomy and sellar irradiation suggest that the etiology of refractory Cushing's disease, in some patients, lies near the sella but not in the pituitary gland. We present 5 patients, out of 626 who received surgery for Cushing's disease, in whom an ACTH-secreting extrapituitary parasellar adenoma was identified: 2 after unsuccessful total hypophysectomy for the treatment of refractory Cushing's disease, 2 after unsuccessful hemihypophysectomy (the first, 2 yr before treatment at the NIH for Nelson's syndrome; and the second, with recurrent Cushing's disease 5 yr after negative transsphenoidal exploration), and 1 with a preoperative diagnosis of an intraclival microadenoma, which was cured by resection of the tumor. In all cases, an extrapituitary parasellar microadenoma was confirmed unequivocally as the cause of the disease, by negative pathology of the resected pituitary gland (patients 1, 2, 3, and 5), and/or the remission of the disease after selective resection of the extrasellar adenoma (patients 3, 4, and 5). Three of 5 patients had a partial empty sella. These patients support the thesis that ACTH-secreting tumors can arise exclusively from remnants of Rathke's pouch, rather than from the adenohypophysis (anterior lobe or pars tuberalis of the pituitary gland) and can be a cause of Cushing's disease. In the sixth presented case, an extrapituitary tumor was suspected at surgery after negative pituitary exploration, but serial sections of the hemihypophysectomy specimen revealed a microscopic focus of tumor at the margin of the resected gland. This case demonstrates the importance of negative pituitary histology to establish the presence of an extrapituitary parasellar tumor as an exclusive source of ACTH, and it supports the value of clinical outcome to establish the diagnosis with selective adenomectomy of an extrapituitary parasellar tumor. In patients with negative pituitary magnetic resonance imaging, especially in the presence of a partial empty sella, the diagnostic and surgical approach in Cushing's disease should consider the identification and resection of extrapituitary parasellar adenoma, which can avoid total hypophysectomy, as was possible in 3 of our 5 patients.
Asunto(s)
Adenoma/metabolismo , Hormona Adrenocorticotrópica/metabolismo , Síndrome de Cushing/etiología , Silla Turca , Adenoma/diagnóstico , Adenoma/patología , Hormona Adrenocorticotrópica/sangre , Adulto , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
Definition of the immune process that causes demyelination in multiple sclerosis is essential to determine the feasibility of Ag-directed immunotherapy. Using the nonhuman primate, Callithrix jacchus jacchus (common marmoset), we show that immunization with myelin basic protein and proteolipid protein determinants results in clinical disease with significant demyelination. Demyelination was associated with spreading to myelin oligodendrocyte glycoprotein (MOG) determinants that generated anti-MOG serum Abs and Ig deposition in central nervous system white matter lesions. These data associate intermolecular "determinant spreading" with clinical autoimmune disease in primates and raise important issues for the pathogenesis and treatment of multiple sclerosis.
Asunto(s)
Enfermedades Desmielinizantes/inmunología , Epítopos/inmunología , Esclerosis Múltiple/inmunología , Adyuvantes Inmunológicos/administración & dosificación , Animales , Autoanticuerpos/biosíntesis , Callithrix , Enfermedades Desmielinizantes/etiología , Enfermedades Desmielinizantes/patología , Modelos Animales de Enfermedad , Epítopos/administración & dosificación , Inyecciones Intradérmicas , Estudios Longitudinales , Imagen por Resonancia Magnética , Esclerosis Múltiple/etiología , Esclerosis Múltiple/patología , Proteína Básica de Mielina/administración & dosificación , Proteína Básica de Mielina/inmunología , Proteínas de la Mielina , Proteína Proteolipídica de la Mielina , Glicoproteína Asociada a Mielina/inmunología , Glicoproteína Mielina-Oligodendrócito , Oligodendroglía/inmunología , Proteínas Recombinantes de Fusión/administración & dosificación , Proteínas Recombinantes de Fusión/inmunologíaRESUMEN
In this study the effect of interferon and anti-CD44 antibody on the invasiveness of mouse glioma G-26 cells was evaluated. We confirmed the glial nature of G-26 glioma cells (G-26) in vitro and in vivo using immunohistochemistry: G-26 stained strongly for S-100 and stained weakly for glial fibrillary acidic protein (GFAP). Immunohistochemical evaluation for CD44 adhesion molecule showed that G-26 was positive both in vitro and in vivo. Weakly positive punctate staining for CD44 was seen in the cytoplasm of all viable glioma cells and focally strong staining was observed in a membranous pattern in the invading glioma cells. Evaluation of untreated G-26 cells using an in vitro invasion assay showed that they were able to digest a Matrigel matrix and to invade through an 8 microns microporous membrane. Treatment of the G-26 glioma cells for 3-4 days with mouse interferon alpha/beta at 8 x 10(2) or 8 x 10(3) mu/ml resulted in a significant decrease of invasiveness: 68.8% (p < 0.05) and 32.8% (p < 0.001) of cells, respectively, remained invasive when compared to control. Treatment of G-26 with antibody to the CD44 adhesion molecule significantly decreased invasiveness with 39.4% (p < 0.001) of cells remaining invasive when compared to control. We feel that both of these approaches, each of which produced significant inhibition of G-26 glioma cell invasion should be further evaluated for their usefulness in antiglioma therapy.
Asunto(s)
Anticuerpos/farmacología , Antineoplásicos/farmacología , Receptores de Hialuranos/inmunología , Interferón-alfa/farmacología , Interferón beta/farmacología , Invasividad Neoplásica/prevención & control , Animales , Movimiento Celular/efectos de los fármacos , Glioma/química , Glioma/patología , Receptores de Hialuranos/análisis , Masculino , Ratones , Ratones Endogámicos C57BL , Células Tumorales Cultivadas/efectos de los fármacosRESUMEN
A missense mutation in the human alpha synuclein gene was recently identified in some cases of familial Parkinson's disease (FPD). We have developed an antibody that recognizes the C-terminal 12 amino acids of the human alpha synuclein protein and have demonstrated that alpha synuclein is an abundant component of the Lewy bodies found within the degenerating neurons of patients with Parkinson's disease (PD). The presence of alpha synuclein in Lewy bodies of sporadic PD patients suggests a central role for alpha synuclein in the pathogenesis of PD.
Asunto(s)
Encéfalo/patología , Cuerpos de Lewy/patología , Proteínas del Tejido Nervioso/análisis , Proteínas del Tejido Nervioso/genética , Enfermedad de Parkinson/genética , Enfermedad de Parkinson/patología , Sustancia Negra/patología , Anciano , Anciano de 80 o más Años , Enfermedad de Alzheimer/genética , Secuencia de Aminoácidos , Cartilla de ADN , Demencia/patología , Exones , Femenino , Humanos , Masculino , Persona de Mediana Edad , Mutación Missense , Proteínas del Tejido Nervioso/inmunología , Neuritas/patología , Neuronas/patología , Fragmentos de Péptidos/química , Fragmentos de Péptidos/inmunología , Fosfoproteínas/análisis , Sinucleínas , alfa-SinucleínaRESUMEN
A peptide derived from the human papillomavirus L2 protein is recognized by a myelin basic protein (MBP)-specific T cell clone from a multiple sclerosis patient and by MBP-specific autoantibodies purified from multiple sclerosis brain tissue. We now show in mice that low doses of this papillomavirus peptide were optimal in selecting a subpopulation of papillomavirus peptide-specific T cells that cross-reacted with MBP(87-99) and with an unrelated viral peptide derived from the BSLF1 protein of Epstein-Barr virus (EBV). These low dose viral peptide- specific T cell lines were highly encephalitogenic. Splenocytes from mice transferred with viral peptide-specific T cells showed a vigorous response to both the papillomavirus and MBP peptides, indicating that viral antigen-specific T cells survived for a prolonged time in vivo. The EBV peptide, unable to prime and select an autoreactive T cell population, could still activate the low dose papillomavirus peptide-specific cells and induce central nervous system (CNS) autoimmunity. Cytokine profiles of papillomavirus peptide-specific encephalitogenic T cells and histopathology of CNS lesions resembled those induced by MBP. These results demonstrate conserved aspects in the recognition of the self-antigen and a cross-reactive viral peptide by human and murine MBP-specific T cell receptors. We demonstrate that a viral antigen, depending on its nature, dose, and number of exposures, may select autoantigen-specific T cells that survive in vivo and can trigger autoimmune disease after adoptive transfer.
Asunto(s)
Antígenos Virales , Encefalomielitis Autoinmune Experimental/etiología , Encefalomielitis Autoinmune Experimental/inmunología , Linfocitos T/inmunología , Secuencia de Aminoácidos , Animales , Antígenos Virales/genética , Autoantígenos , Supervivencia Celular , Reacciones Cruzadas , Citomegalovirus/genética , Citomegalovirus/inmunología , Encefalomielitis Autoinmune Experimental/patología , Femenino , Cobayas , Herpesvirus Humano 4/genética , Herpesvirus Humano 4/inmunología , Humanos , Inmunización Pasiva , Técnicas In Vitro , Activación de Linfocitos , Ratones , Imitación Molecular , Datos de Secuencia Molecular , Proteína Básica de Mielina/genética , Proteína Básica de Mielina/inmunología , Proteínas Oncogénicas Virales/genética , Proteínas Oncogénicas Virales/inmunología , Papillomaviridae/genética , Papillomaviridae/inmunología , Fragmentos de Péptidos/genética , Fragmentos de Péptidos/inmunología , Linfocitos T/citologíaRESUMEN
We compared the activity of Ib spinal interneurons in five patients with progressive supranuclear palsy (PSP) with six age-matched control subjects. Stimulation of the medial gastrocnemius nerve at motor threshold intensity activated Ib afferents that in turn inhibit H reflexes from the soleus muscle. Maximum inhibition occurred at interstimulus intervals of 6 and 8 ms for both control subjects and PSP patients and was significantly greater in the PSP patients. Increased Ib activity of PSP patients may be caused by loss of inhibition of Ib interneurons through degeneration of the medullary reticulospinal pathway. The corticospinal pathways, unopposed by the medullary reticulospinal tract, may excessively activate Ib interneurons.
Asunto(s)
Interneuronas/fisiología , Inhibición Neural/fisiología , Médula Espinal/fisiopatología , Parálisis Supranuclear Progresiva/fisiopatología , Vías Aferentes/patología , Vías Aferentes/fisiopatología , Anciano , Anciano de 80 o más Años , Mapeo Encefálico , Estimulación Eléctrica , Femenino , Reflejo H/fisiología , Humanos , Técnicas para Inmunoenzimas , Interneuronas/patología , Masculino , Mecanorreceptores/patología , Mecanorreceptores/fisiopatología , Persona de Mediana Edad , Músculo Esquelético/inervación , Tiempo de Reacción/fisiología , Formación Reticular/patología , Formación Reticular/fisiopatología , Médula Espinal/patología , Parálisis Supranuclear Progresiva/diagnóstico , Parálisis Supranuclear Progresiva/patologíaRESUMEN
MION-46L, a superparamagnetic iron oxide contrast agent, was investigated for its ability to increase the sensitivity of in vivo 3D MRI in the detection of brain lesions in a chronic experimental allergic encephalomyelitis (crEAE) mouse model. Lesion conspicuity on postcontrast 3D MRI was dramatically enhanced as compared to precontrast images corresponding to areas of inflammatory and demyelinating lesions. MION-46L could be detected on Prussian blue iron stain in the vascular endothelium, the perivascular space, and in macrophages within perivascular cuffs and areas of inflammation and demyelination. By taking advantage of the MION-46L induced macroscopic susceptibility effect, acute early lesions measuring only 100 microm in diameter could be detected. MION-46L enhanced MRI may be used to 1) provide a unique sensitivity in EAE lesion detection and correlate imaging to histopathology; 2) help to understand EAE lesion development and its underlying pathophysiology; and 3) eventually assist in preclinical screening of new experimental therapies directed at patients with multiple sclerosis (MS).